Brian N Finck Selected Research

2-acylglycerol O-acyltransferase

1/2021	Monoacylglycerol Acyltransferase 1 Knockdown Exacerbates Hepatic Ischemia/Reperfusion Injury in Mice With Hepatic Steatosis.
10/2014	Inhibiting monoacylglycerol acyltransferase 1 ameliorates hepatic metabolic abnormalities but not inflammation and injury in mice.
7/2014	Abrogating monoacylglycerol acyltransferase activity in liver improves glucose tolerance and hepatic insulin signaling in obese mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Brian N Finck Research Topics

Disease

23	Insulin Resistance 01/2022 - 08/2003
17	Obesity 01/2022 - 02/2005
14	Non-alcoholic Fatty Liver Disease 12/2021 - 05/2012
10	Inflammation (Inflammations) 01/2022 - 06/2010
7	Weight Loss (Weight Reduction) 01/2021 - 03/2007
7	Type 2 Diabetes Mellitus (MODY) 01/2021 - 07/2004
6	Fibrosis (Cirrhosis) 12/2021 - 01/2017
6	Fatty Liver 05/2020 - 09/2006
5	Diabetic Cardiomyopathies 08/2008 - 01/2002
4	Neoplasms (Cancer) 01/2022 - 10/2006
4	Cardiomegaly (Heart Hypertrophy) 10/2021 - 10/2002
4	Glucose Intolerance 08/2016 - 02/2005
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2014 - 11/2006
3	Hyperglycemia 01/2022 - 08/2003
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 01/2017
3	Metabolic Diseases (Metabolic Disease) 12/2021 - 01/2007
3	Rhabdomyolysis 10/2021 - 01/2015
3	Body Weight (Weight, Body) 01/2021 - 02/2010
3	Atherosclerosis 01/2021 - 11/2006
3	Cardiomyopathies (Cardiomyopathy) 04/2007 - 01/2002
2	Liver Diseases (Liver Disease) 01/2022 - 01/2021
2	Reperfusion Injury 01/2021 - 01/2006
2	Ischemia 01/2021 - 01/2006
2	Heart Failure 11/2020 - 03/2006
2	Necrosis 01/2019 - 01/2018
2	Hypercholesterolemia 01/2018 - 08/2011
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2012 - 01/2005
2	Ventricular Dysfunction 04/2011 - 01/2002
2	Hyperinsulinism (Hyperinsulinemia) 09/2007 - 08/2003
2	Diabetes Mellitus 04/2007 - 01/2002
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2022
1	Heart Diseases (Heart Disease) 01/2022
1	Chronic Renal Insufficiency 12/2021
1	Rupture 01/2021
1	Hepatocellular Carcinoma (Hepatoma) 01/2021
1	Liver Failure 01/2021
1	Ketosis 11/2020
1	Body Weight Changes 01/2019
1	Muscular Diseases (Myopathy) 01/2019
1	Vitamin D Deficiency 01/2019

Drug/Important Bio-Agent (IBA)

22	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2002
14	Insulin (Novolin)FDA Link 01/2022 - 09/2005
12	LipidsIBA 12/2021 - 02/2003
10	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2004
10	lipineIBA 10/2021 - 09/2006
10	Triglycerides (Triacylglycerol)IBA 10/2021 - 02/2003
10	Fatty Acids (Saturated Fatty Acids)IBA 10/2020 - 01/2002
10	PPAR alphaIBA 04/2007 - 01/2002
7	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2018 - 01/2002
6	DiglyceridesIBA 01/2021 - 07/2014
6	EnzymesIBA 01/2021 - 01/2006
5	Pyruvic Acid (Pyruvate)IBA 01/2022 - 06/2014
4	CholesterolIBA 01/2021 - 08/2011
4	Messenger RNA (mRNA)IBA 01/2021 - 12/2006
4	CarbohydratesIBA 11/2020 - 05/2009
4	Monocarboxylic Acid TransportersIBA 11/2020 - 08/2016
4	Blood Glucose (Blood Sugar)IBA 01/2019 - 06/2014
4	FructoseIBA 06/2017 - 11/2013
3	2-acylglycerol O-acyltransferaseIBA 01/2021 - 07/2014
3	Transcription Factors (Transcription Factor)IBA 01/2019 - 12/2004
3	Phosphatidate PhosphataseIBA 01/2019 - 03/2009
3	LigandsIBA 01/2018 - 07/2004
3	MSDC-0602IBA 01/2017 - 07/2012
3	Dietary Fats (Dietary Fat)IBA 05/2009 - 02/2003
2	Alanine Transaminase (SGPT)IBA 01/2022 - 01/2018
2	Amino Acids FDA Link 01/2022 - 12/2021
2	Bile Acids and Salts (Bile Acids)IBA 12/2021 - 08/2010
2	RNA (Ribonucleic Acid)IBA 01/2021 - 12/2018
2	Antisense OligonucleotidesIBA 01/2021 - 01/2021
2	MonoglyceridesIBA 01/2021 - 07/2014
2	LDL Lipoproteins (beta Lipoproteins)IBA 01/2021 - 01/2018
2	AdiponectinIBA 01/2021 - 03/2007
2	Branched-Chain Amino AcidsIBA 01/2021 - 08/2013
2	fibroblast growth factor 21IBA 12/2018 - 06/2009
2	CytokinesIBA 01/2018 - 09/2005
2	Protein Kinase CIBA 01/2015 - 07/2014
2	Interleukin-6 (Interleukin 6)IBA 08/2008 - 09/2005
2	PPAR gammaIBA 12/2006 - 10/2006
1	CarbonIBA 01/2022
1	NexusIBA 01/2022
1	Pharmaceutical PreparationsIBA 12/2021
1	lipoarabinomannan (LAM)IBA 12/2021
1	Chemokine ReceptorsIBA 12/2021
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2021
1	Interferon alpha-beta Receptor (Receptor, Interferon alpha beta)IBA 01/2021
1	KetonesIBA 11/2020
1	NADP (NADPH)IBA 05/2020
1	Glutathione (Reduced Glutathione)IBA 05/2020
1	Phosphatidic Acids (Phosphatidic Acid)IBA 01/2019
1	Vitamin D FDA LinkGeneric 01/2019
1	Peptide Hormones (Polypeptide Hormones)IBA 01/2019
1	thiamine triphosphorate (TTP)IBA 12/2018
1	TristetraprolinIBA 12/2018
1	Glucagon-Like Peptide 1 (GLP 1)IBA 11/2018

Therapy/Procedure

4	Therapeutics 01/2022 - 08/2010
4	Gastric Bypass (Roux-en-Y Gastric Bypass) 08/2013 - 03/2007
2	Bariatric Surgery 01/2022 - 01/2021
2	Liver Transplantation 01/2021 - 01/2018
2	Transplantation 01/2021 - 11/2006
2	Glycemic Control 01/2019 - 11/2018